Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Conversion Disorder”

488 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 488 results

Not applicableNot Yet RecruitingNCT07410715
What this trial is testing

Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular Carcinoma (SWITCH)

Who this might be right for
HCC - Hepatocellular CarcinomaWatch & WaitSurgery
West China Hospital 100
Not applicableStudy completedNCT06558760
What this trial is testing

Changes in the Treatment of Acute Appendicitis

Who this might be right for
Acute Appendicitis
Medizinische Hochschule Brandenburg Theodor Fontane 31,988
Testing effectiveness (Phase 2)UnknownNCT05541146
What this trial is testing

Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis

Who this might be right for
Gastric CancerPeritoneal Carcinomatosis
Instituto do Cancer do Estado de São Paulo 30
Not applicableNot Yet RecruitingNCT07006415
What this trial is testing

Brain-computer Interface Rehabilitation And Virtual Environments in Functional Neurological Disorder (BRAVE-FND)

Who this might be right for
Functional Neurological DisorderConversion DisorderFunctional Neurological Disorders+1 more
King's College London 24
Not applicableStudy completedNCT04392323
What this trial is testing

Incidence of COVID-19 Test Conversion in Post-surgical Patients

Who this might be right for
Sars-CoV2
Northwell Health 111
Not applicableStudy completedNCT01425957
What this trial is testing

Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment

Who this might be right for
MILD COGNITIVE IMPAIRMENT
Qualissima 229
Not applicableWithdrawnNCT06346873
What this trial is testing

Demonstrating Efficacy of JOGO for the Treatment of Tremor

Who this might be right for
Functional Neurological Disorder
Mayo Clinic
Not applicableEnded earlyNCT00292097
What this trial is testing

A Prospective, Randomized Trial of Early Versus Late Tracheostomy in Trauma Patients With Severe Brain Injury

Who this might be right for
Respiratory FailureTraumatic Brain Injury
Memorial Medical Center 5
Not applicableStudy completedNCT01053286
What this trial is testing

Stimulation of Sensation and Improvement in Swallowing Using Oral Capsaicin

Who this might be right for
DysphagiaGastroesophageal Reflux
University of California, Davis 19
Large-scale testing (Phase 3)Study completedNCT01817166
What this trial is testing

Efficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolated Syndrome

Who this might be right for
Multiple Sclerosis
Centre Hospitalier Universitaire de Nīmes 316
Not applicableLooking for participantsNCT06382103
What this trial is testing

Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 240
Testing effectiveness (Phase 2)Study completedNCT04124705
What this trial is testing

Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants

Who this might be right for
HypothyroidismThyroid DiseaseEuthyroid+2 more
Allergan 284
Not applicableStudy completedNCT04739176
What this trial is testing

Mirror Therapy Rehabilitation for Motor Functional Neurological Disorders.

Who this might be right for
Functional Neurological Symptom Disorder
Hospices Civils de Lyon 5
Post-approval studies (Phase 4)WithdrawnNCT02058875
What this trial is testing

Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring

Who this might be right for
Cardiovascular DiseaseCardiovascular OutcomesKidney Transplant Recipients+1 more
University of Saskatchewan
Testing effectiveness (Phase 2)Active Not RecruitingNCT06766019
What this trial is testing

Adebrelimab Combined With Irinotecan Liposomal (II), Oxaliplatin, and 5-FU/LV Conversion Therapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
The First Affiliated Hospital with Nanjing Medical University 47
Large-scale testing (Phase 3)WithdrawnNCT05082571
What this trial is testing

Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease

Who this might be right for
Anemia of Chronic Kidney Disease
Akebia Therapeutics
Not applicableStudy completedNCT02225964
What this trial is testing

Multi-modality MRI Study on Differences in Conversion of aMCI Patients With APOEε4 to AD

Who this might be right for
Mild Cognitive Impairment
XuanwuH 2 200
Large-scale testing (Phase 3)Study completedNCT02124564
What this trial is testing

A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures

Who this might be right for
EpilepsyPartial-onset Seizures
UCB Japan Co. Ltd. 19
Post-approval studies (Phase 4)Study completedNCT00418600
What this trial is testing

A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis

Who this might be right for
Secondary Hyperparathyroidism
Genzyme, a Sanofi Company 36
Not applicableLooking for participantsNCT06330467
What this trial is testing

Prevalence of Dissociative Identity Disorder in At-risk Outpatient Groups Reporting Childhood Trauma.

Who this might be right for
Dissociative Disorder
Centre Psychothérapique de Nancy 350
Load More Results